328 related articles for article (PubMed ID: 30529023)
1. Vaccinating children against influenza increases variability in epidemic size.
Backer JA; van Boven M; van der Hoek W; Wallinga J
Epidemics; 2019 Mar; 26():95-103. PubMed ID: 30529023
[TBL] [Abstract][Full Text] [Related]
2. The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015.
Backer JA; Wallinga J; Meijer A; Donker GA; van der Hoek W; van Boven M
Epidemics; 2019 Mar; 26():77-85. PubMed ID: 30344024
[TBL] [Abstract][Full Text] [Related]
3. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
de Boer PT; Backer JA; van Hoek AJ; Wallinga J
BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
[TBL] [Abstract][Full Text] [Related]
4. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
5. Variation in loss of immunity shapes influenza epidemics and the impact of vaccination.
Woolthuis RG; Wallinga J; van Boven M
BMC Infect Dis; 2017 Sep; 17(1):632. PubMed ID: 28927373
[TBL] [Abstract][Full Text] [Related]
6. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.
Pitman RJ; White LJ; Sculpher M
Vaccine; 2012 Feb; 30(6):1208-24. PubMed ID: 22178725
[TBL] [Abstract][Full Text] [Related]
7. Universal influenza vaccination and live attenuated influenza vaccination of children.
Glezen WP
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
[TBL] [Abstract][Full Text] [Related]
9. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
Baguelin M; Camacho A; Flasche S; Edmunds WJ
BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
[TBL] [Abstract][Full Text] [Related]
10. Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation.
Hill EM; Petrou S; Forster H; de Lusignan S; Yonova I; Keeling MJ
PLoS Comput Biol; 2020 Oct; 16(10):e1008278. PubMed ID: 33021983
[TBL] [Abstract][Full Text] [Related]
11. Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Sandmann FG; van Leeuwen E; Bernard-Stoecklin S; Casado I; Castilla J; Domegan L; Gherasim A; Hooiveld M; Kislaya I; Larrauri A; Levy-Bruhl D; Machado A; Marques DFP; Martínez-Baz I; Mazagatos C; McMenamin J; Meijer A; Murray JLK; Nunes B; O'Donnell J; Reynolds A; Thorrington D; Pebody R; Baguelin M
Vaccine; 2022 Feb; 40(9):1306-1315. PubMed ID: 35109968
[TBL] [Abstract][Full Text] [Related]
12. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
Müller D; Szucs TD
Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
[TBL] [Abstract][Full Text] [Related]
14. Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.
Gerlier L; Lamotte M; Dos Santos Mendes S; Damm O; Schwehm M; Eichner M
Paediatr Drugs; 2016 Aug; 18(4):303-18. PubMed ID: 27272706
[TBL] [Abstract][Full Text] [Related]
15. Is the impact of childhood influenza vaccination less than expected: a transmission modelling study.
Weidemann F; Remschmidt C; Buda S; Buchholz U; Ultsch B; Wichmann O
BMC Infect Dis; 2017 Apr; 17(1):258. PubMed ID: 28399801
[TBL] [Abstract][Full Text] [Related]
16. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
[TBL] [Abstract][Full Text] [Related]
17. Optimal strategies of social distancing and vaccination against seasonal influenza.
Shim E
Math Biosci Eng; 2013; 10(5-6):1615-34. PubMed ID: 24245639
[TBL] [Abstract][Full Text] [Related]
18. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.
Basta NE; Chao DL; Halloran ME; Matrajt L; Longini IM
Am J Epidemiol; 2009 Sep; 170(6):679-86. PubMed ID: 19679750
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccination coverage in the 2004/05, 2005/06, and 2006/07 seasons: a secondary data analysis based on billing data of the German associations of statutory health insurance physicians.
Reuss AM; Walter D; Feig M; Kappelmayer L; Buchholz U; Eckmanns T; Poggensee G
Dtsch Arztebl Int; 2010 Dec; 107(48):845-50. PubMed ID: 21173931
[TBL] [Abstract][Full Text] [Related]
20. Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017-2018 winter influenza season.
Ho SH; He D; Eftimie R
J Theor Biol; 2019 Sep; 476():74-94. PubMed ID: 31128142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
